Livongo Health, Inc. (NASDAQ: LVGO) today announced the pricing of its underwritten public offering of 2,777,327 shares of its common stock by certain selling stockholders at a price of $27.00 per share. Such selling stockholders have also granted the underwriters a30-dayoption to purchase up to an additional 416,598 shares of common stock at the public offering price, less underwriting discounts and commissions. Livongo will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders, and will bear the costs associated with the sale of such shares, other than underwriting discounts and commissions.
This offering is expected to close on or about December 16, 2019, subject to the satisfaction of customary closing conditions.
Morgan Stanley& Co. LLC, Goldman Sachs& Co. LLC, and J.P. Morgan Securities LLC are acting as lead joint book-running managers for the offering.